BioSpace News Archive

RareStone Inc., formerly Citrine Medicine, a China-based rare disease therapeutics company, today announced its submission of a New Drug Application (NDA) for Wakix® (pitolisant)

Mirimus, Inc. today announced a strategic collaboration with Biogen Inc. (NASDAQ: BIIB) focused on the development of RNAi-based therapeutics targeting multiple, undisclosed neurological disease indications.

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2021 financial results on Wednesday, August 4, 2021, before the open of the US financial markets.

Alnylam Pharmaceuticals, Inc. announced today that it will report financial results for the second quarter ending June 30, 2021 on Tuesday, August 3, 2021, before the U.S. financial markets open.

Alloy Therapeutics and Echo Investment Capital today announced the formation of Wheeler Bio, a new biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact.

Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based protein revolution, announced an expansion to its Series B round to a total of $7 million with new investment from the global player and stock listed company BayWa AG.

Omniscient Neurotechnology today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Quicktome™, a digital brain mapping platform that allows neurosurgeons to visualize and understand a patient’s brain networks prior to performing life-changing brain surgery.

ArcScan, Inc. announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. (“Haohai”) that will result in a $11.15 million Preferred Series B investment into ArcScan, Inc.

Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo Fisher Scientific aimed at addressing challenges in commercial-scale viral vector manufacturing

Royal Phillips announced the FDA has granted Breakthrough Device Designation for a laser assisted inferior vena cava filter removal device.